Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

Antibody deficiency is the most frequently encountered primary immunodeficiency disease (PIDD) and patients who lack the ability to make functional immunoglobulin require life-long replacement therapy to prevent serious bacterial infections. Human serum immunoglobulin manufactured from pools of dona...

Descripción completa

Detalles Bibliográficos
Autores principales: Skoda-Smith, Suzanne, Torgerson, Troy R, Ochs, Hans D
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817783/
https://www.ncbi.nlm.nih.gov/pubmed/20169031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817783/
https://www.ncbi.nlm.nih.gov/pubmed/20169031

Ejemplares similares